The Canadian Competition Authority closes two investigations into pharmaceutical patent litigation settlements

Competition Bureau closes two investigations into pharmaceutical patent litigation settlements* Bureau proactively monitors settlements between drug manufacturers to identify potentially illegal agreements The investigations were launched as a result of the Bureau’s proactive monitoring of agreements between branded and generic drug

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Canadian Competition Bureau, The Canadian Competition Authority closes two investigations into pharmaceutical patent litigation settlements, 20 May 2022, e-Competitions July 2022, Art. N° 107265

Visites 56

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues